MDT guided by PSMA-based imaging has shown promising results in patients with hormone-naïve oligometastatic recurrent PCa (Beauval et al., 2018; Kneebone et al., 2018; Ost et al., 2018; Siva et al., 2018). Here, FOLH1 is linked to posterior cortical atrophy.